The global MRI contrast media agents market size is expected to reach USD 3.42 billion by 2030, registering a CAGR of 7.15% during the forecast period. The factors anticipated to propel the growth include the rising prevalence of chronic diseases and the rising demand for early diagnosis. It is anticipated that the increasing number of clinical trials to determine the efficacy and efficiency of MRI contrast media agents in various clinical applications will spur market expansion.
According to WHO, chronic diseases will account for three-quarters of all deaths worldwide by 2020. Prevention of chronic diseases is possible if patients are diagnosed and treated early. However, to date, only four companies, Bayer AG, GE Healthcare LLC, Guerbet GmbH, and Bracco Imaging SpA are actively involved in the manufacture of MRI contrast agents, which creates tremendous opportunities for small businesses as well as the largest organization.
The early diagnosis of chronic diseases, such as cancer, cardiac diseases, and neurological disorders, significantly increases prognosis by enabling on-time treatment. Cancer and cardiovascular diseases together result in the highest global mortality rate. This has captured the attention of various governments & healthcare organizations and is driving them to work toward creating awareness regarding these diseases.
Companies like Miltenyi Biotec B.V. & Co. Kg, Reveal Pharma, and others have developed contrast media agents and are currently in the preclinical stage. The efficacy, safety, and in vivo compatibility of contrast agent makes them critical for receiving FDA approval. Several government initiatives to develop modern healthcare centers and also provide financial support for new MRI machines are driving the growth of the MRI contrast media agents industry. However, the reduction in diagnostic scans during the COVID-19 pandemic, the halt of logistics, and the development of generic products contributed to a decline in the market in 2020 and 2021. However, it is expected to bounce back by late 2022.
This product will be delivered within 1-3 business days.
According to WHO, chronic diseases will account for three-quarters of all deaths worldwide by 2020. Prevention of chronic diseases is possible if patients are diagnosed and treated early. However, to date, only four companies, Bayer AG, GE Healthcare LLC, Guerbet GmbH, and Bracco Imaging SpA are actively involved in the manufacture of MRI contrast agents, which creates tremendous opportunities for small businesses as well as the largest organization.
The early diagnosis of chronic diseases, such as cancer, cardiac diseases, and neurological disorders, significantly increases prognosis by enabling on-time treatment. Cancer and cardiovascular diseases together result in the highest global mortality rate. This has captured the attention of various governments & healthcare organizations and is driving them to work toward creating awareness regarding these diseases.
Companies like Miltenyi Biotec B.V. & Co. Kg, Reveal Pharma, and others have developed contrast media agents and are currently in the preclinical stage. The efficacy, safety, and in vivo compatibility of contrast agent makes them critical for receiving FDA approval. Several government initiatives to develop modern healthcare centers and also provide financial support for new MRI machines are driving the growth of the MRI contrast media agents industry. However, the reduction in diagnostic scans during the COVID-19 pandemic, the halt of logistics, and the development of generic products contributed to a decline in the market in 2020 and 2021. However, it is expected to bounce back by late 2022.
MRI Contrast Media Agents Market Report Highlights
- The adoption of advanced imaging technologies is augmenting the growth of the MRI and MRI contrast media agents industry
- Paramagnetic agents are anticipated to be the fastest-growing segment during the forecast period due to the efficiency and wide adoption of these agents by radiologists
- MRI contrast media agents for neurological imaging dominated the market in 2022, due to the growing number of neurological diseases and increased demand for less invasive diagnostic procedures
- Hospital accounted for the largest share of the end-use segment in 2022, due to the treatment of chronic illnesses in the hospitals and high financial support
- Clinical research accounted for the largest share based on type, in 2022
- In 2022, North America dominated the global space with the largest revenue share, owing to continuous research and high adoption of advanced diagnostic techniques in the region
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Methodology and Scope1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Type
1.1.3 Applications
1.1.4 End-use
1.1.5 Regional Scope
1.1.6 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for Primary Interviews in Europe
1.3.5.3 Data for Primary Interviews in Europe
1.3.5.4 Data for Primary Interviews in Rest of the world
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective 1:
1.8.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Product Outlook
2.2.2 Type Outlook
2.2.3 Application Outlook
2.2.4 Regional Outlook
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration & Growth Prospect Mapping
3.2.1 Reimbursement framework
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Rising patient population
3.3.1.2 Technological advancement
3.3.1.3 Increasing awareness regarding early diagnosis
3.3.2 Market Restraint Analysis
3.3.2.1 High cost of MRI contrast media agents
3.4 Magnetic Resonance Imaging Market Analysis Tools
3.4.1 Industry Analysis - Porter’s
3.4.1.1 Supplier Power
3.4.1.2 Buyer Power
3.4.1.3 Substitution Threat
3.4.1.4 Threat from new entrant
3.4.1.5 Competitive rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political Landscape
3.4.2.2 Technological Landscape
3.4.2.3 Economic Landscape
3.4.3 Major Deals & Strategic Alliances Analysis
3.4.4 Market Entry Strategies
Chapter 4 Type Business Analysis
4.1 Definitions and Scope
4.1.1 Paramagnetic agents
4.1.2 Superparamagnetic agents
4.2 Product Market Share Analysis
4.3 Segment Dashboard
4.4 Global Magnetic Resonance Imaging Market by Product
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.6 Paramagnetic agents
4.6.1 Paramagnetic Agents Market Estimates And Forecast, 2018 - 2030
4.7 Superparamagnetic agents
4.7.1 Superparamagnetic Agents Market Estimates And Forecast, 2018 - 2030
Chapter 5 Type Business Analysis
5.1 Definitions and Scope
5.1.1 Clinical
5.1.2 Preclinical
5.2 Type Market Share Analysis
5.3 Segment Dashboard
5.4 Global Magnetic Resonance Imaging Market by Type
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1 Clinical
5.5.1.1 Clinical Market Estimates And Forecast, 2018 - 2030
5.5.2 Preclinical
5.5.2.1 Preclinical Market Estimates and Forecast, 2018 - 2030
Chapter 6 Application Business Analysis
6.1 Definitions and Scope
6.1.1 Gastrointestinal
6.1.2 Intravenous
6.1.3 Hepatobiliary
6.1.4 Neurological Imaging
6.1.5 Others
6.2 Application Market Share Analysis
6.3 Segment Dashboard
6.4 Global Magnetic Resonance Imaging Market by Application
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1 Gastrointestinal
6.5.1.1 Gastrointestinal Market Estimates And Forecast, 2018 - 2030
6.5.2 Intravenous
6.5.2.1 Intravenous Market Estimates And Forecast, 2018 - 2030
6.5.3 Hepatobiliary
6.5.3.1 Hepatobiliary Market Estimates and Forecast, 2018 - 2030
6.5.4 Neurological Imaging
6.5.4.1 Neurological Imaging Market Estimates and Forecast, 2018 - 2030
6.5.5 Others
6.5.5.1 Others Market Estimates and Forecast, 2018 - 2030
Chapter 7 End-use Business Analysis
7.1 Definitions and Scope
7.2 Type Market Share Analysis
7.3 Segment Dashboard
7.4 Global Magnetic Resonance Imaging Market by End-use
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5.1 Hospitals
7.5.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030
7.5.2 Imaging centers
7.5.2.1 Imaging centers Market Estimates and Forecast, 2018 - 2030
Chapter 8 Magnetic Resonance Imaging Market: Regional Market Analysis, 2018 - 2030 (Value & Volume) (USD Million)
8.1 Regional market share analysis, 2022 & 2030
8.2 Regional Market Dashboard
8.3 Global Regional Market Snapshot
8.4 Regional Market Share and Leading Players
8.4.1 North America
8.4.2 Europe
8.4.3 Asia Pacific
8.4.4 Latin America
8.4.5 Middle East & Africa
8.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
8.5.1 North America
8.5.2 Europe
8.5.3 Asia Pacific
8.5.4 Latin America
8.5.5 Middle East & Africa
8.6 Market Size, & Forecasts, Volume and Trend Analysis, 2022 to 2030:
8.7 North America
8.7.1 Market estimates and forecast, 2018 - 2030
8.7.2 U.S.
8.7.2.1 U.S. market estimates and forecast, 2018 - 2030
8.7.3 Canada
8.7.3.1 Canada market estimates and forecast, 2018 - 2030
8.8 Europe
8.8.1 Europe market estimates and forecast, 2018 - 2030
8.8.2 Germany
8.8.2.1 Germany market estimates and forecast, 2018 - 2030
8.8.3 U.K.
8.8.3.1 U.K. market estimates and forecast, 2018 - 2030
8.8.4 France
8.8.4.1 France market estimates and forecast, 2018 - 2030
8.8.5 Italy
8.8.5.1 Italy market estimates and forecast, 2018 - 2030
8.8.6 Spain
8.8.6.1 Spain market estimates and forecast, 2018 - 2030
8.8.7 Norway
8.8.7.1 Norway market estimates and forecast, 2018 - 2030
8.8.8 Sweden
8.8.8.1 Sweden market estimates and forecast, 2018 - 2030
8.8.9 Denmark
8.8.9.1 Denmark market estimates and forecast, 2018 - 2030
8.9 Asia Pacific
8.9.1 Asia Pacific market estimates and forecast, 2018 - 2030
8.9.2 China
8.9.2.1 China market estimates and forecast, 2018 - 2030
8.9.3 Japan
8.9.3.1 Japan market estimates and forecast, 2018 - 2030
8.9.4 India
8.9.4.1 India market estimates and forecast, 2018 - 2030
8.9.5 South Korea
8.9.5.1 South Korea market estimates and forecast, 2018 - 2030
8.9.6 Australia
8.9.6.1 Australia market estimates and forecast, 2018 - 2030
8.9.7 Thailand
8.9.7.1 Thailand market estimates and forecast, 2018 - 2030
8.10 Latin America
8.10.1 Latin America market estimates and forecast, 2018 - 2030
8.10.2 Brazil
8.10.2.1 Brazil market estimates and forecast, 2018 - 2030
8.10.3 Mexico
8.10.3.1 Mexico market estimates and forecast, 2018 - 2030
8.10.4 Argentina
8.10.4.1 Argentina market estimates and forecast, 2018 - 2030
8.11 Middle East and Africa
8.11.1 Market estimates and forecast, 2018 - 2030
8.11.2 South Africa
8.11.2.1 South Africa market estimates and forecast, 2018 - 2030
8.11.3 Saudi Arabia
8.11.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030
8.11.4 UAE
8.11.4.1 UAE market estimates and forecast, 2018 - 2030
8.11.5 Argentina
8.11.5.1 Argentina market estimates and forecast, 2018 - 2030
Chapter 9 Magnetic Resonance Imaging Market: Competitive Market Analysis
9.1 Recent Developments & Impact Analysis, By Key Market Participants
9.2 Company/Competition Categorization
9.2.1 Innovators
9.3 Vendor Landscape
9.3.1 List of Key Distributors and Channel Partners
9.3.2 Key customers
9.3.3 Key company market share analysis, 2022
9.3.4 GE Healthcare
9.3.5 Bayer AG
9.3.6 Guerbet GmbH
9.3.7 Bracco Imaging Spa
9.3.8 Vitalquan, LLC
9.3.9 Miltenyi Biotec B.V. & Co. Kg
List of Tables
1. List of Abbreviation
2. North America MRI Contrast Media Agents Market, by region, 2018 - 2030 (USD Million)
3. North America MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
4. North America MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
5. North America MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
6. North America MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
7. U.S. MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
8. U.S. MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
9. U.S. MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
10. U.S. MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
11. Canada MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
12. Canada MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
13. Canada MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
14. Canada MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
15. Europe MRI Contrast Media Agents Market, by region, 2018 - 2030 (USD Million)
16. Europe MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
17. Europe MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
18. Europe MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
19. Europe MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
20. U.K. MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
21. U.K. MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
22. U.K. MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
23. U.K. MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
24. Germany MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
25. Germany MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
26. Germany MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
27. Germany MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
28. Spain MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
29. Spain MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
30. Spain MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
31. Spain MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
32. France MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
33. France MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
34. France MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
35. France MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
36. Italy MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
37. Italy MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
38. Italy MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
39. Italy MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
40. Norway MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
41. Norway MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
42. Norway MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
43. Norway MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
44. Sweden MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
45. Sweden MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
46. Sweden MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
47. Sweden MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
48. Denmark MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
49. Denmark MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
50. Denmark MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
51. Denmark MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
52. Asia Pacific MRI Contrast Media Agents Market, by Region, 2018 - 2030 (USD Million)
53. Asia Pacific MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
54. Asia Pacific MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
55. Asia Pacific MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
56. Asia Pacific MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
57. China MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
58. China MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
59. China MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
60. China MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
61. India MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
62. India MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
63. India MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
64. India MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
65. Japan MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
66. Japan MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
67. Japan MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
68. Japan MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
69. South Korea MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
70. South Korea MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
71. South Korea MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
72. South Korea MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
73. Australia MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
74. Australia MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
75. Australia MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
76. Australia MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
77. Thailand MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
78. Thailand MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
79. Thailand MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
80. Thailand MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
81. Latin America MRI Contrast Media Agents Market, by Region, 2018 - 2030 (USD Million)
82. Latin America MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
83. Latin America MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
84. Latin America MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
85. Latin America MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
86. Brazil MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
87. Brazil MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
88. Brazil MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
89. Brazil MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
90. Mexico MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
91. Mexico MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
92. Mexico MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
93. Mexico MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
94. Argentina MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
95. Argentina MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
96. Argentina MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
97. Argentina MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
98. MEA MRI Contrast Media Agents Market, by Region, 2018 - 2030 (USD Million)
99. MEA MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
100. MEA MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
101. MEA MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
102. MEA MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
103. South Africa MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
104. South Africa MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
105. South Africa MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
106. South Africa MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
107. Saudi Arabia MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
108. Saudi Arabia MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
109. Saudi Arabia MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
110. Saudi Arabia MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
111. UAE MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
112. UAE MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
113. UAE MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
114. UAE MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
115. Kuwait MRI Contrast Media Agents Market, by Product, 2018 - 2030 (USD Million)
116. Kuwait MRI Contrast Media Agents Market, by Type, 2018 - 2030 (USD Million)
117. Kuwait MRI Contrast Media Agents Market, by Application, 2018 - 2030 (USD Million)
118. Kuwait MRI Contrast Media Agents Market, by End-use, 2018 - 2030 (USD Million)
List of Figures
1. Market research process
2. Data triangulation techniques
3. Primary research pattern
4. Primary interviews in North America
5. Primary interviews in Europe
6. Primary interviews in APAC
7. Primary interviews in Latin America
8. Primary interviews in MEA
9. Market research approaches
10. Value-chain-based sizing & forecasting
11 QFD modeling for market share assessment
12. Market formulation & validation
13. MRI contrast media agents market: market outlook
14. MRI contrast media agents market competitive insights
15. Parent market outlook
16. Related/ancillary market outlook
17. Penetration and growth prospect mapping
18. Industry value chain analysis
19. MRI contrast media agents market driver impact
20. MRI contrast media agents market restraint impact
21. MRI contrast media agents market strategic initiatives analysis
22. MRI contrast media agents market: Product movement analysis
23. MRI contrast media agents market: Product outlook and key takeaways
24. Superparamagnetic agents market estimates and forecast, 2018 - 2030
25. Paramagnetic agents market estimates and forecast, 2018 - 2030
26. MRI contrast media agents market: Type movement analysis
27. MRI contrast media agents market: Type outlook and key takeaways
28. Clinical market estimates and forecast, 2018 - 2030
29. Preclinical market estimates and forecast, 2018 - 2030
30. High Type market estimates and forecast, 2018 - 2030
31. MRI contrast media agents market: application movement analysis
32. MRI contrast media agents market: application outlook and key takeaways
33. Gastrointestinal market estimates and forecast, 2018 - 2030
34. Intravenous market estimates and forecast, 2018 - 2030
35. Hepatobiliary market estimates and forecast, 2018 - 2030
36. Neurological Imaging market estimates and forecast, 2018 - 2030
37. Others market estimates and forecast, 2018 - 2030
38. MRI contrast media agents market: end-use movement analysis
39. MRI contrast media agents market: end-use outlook and key takeaways
40. Hospitals market estimates and forecast, 2018 - 2030
41. Imaging centers estimates and forecast, 2018 - 2030
42. Global MRI contrast media agents market: Regional movement analysis
43. Global MRI contrast media agents market: regional outlook and key takeaways
44. Global market share and leading players
45. North America market share and leading players
46. Europe market share and leading players
47. Asia Pacific market share and leading players
48. Latin America market share and leading players
49. Middle East & Africa market share and leading players
50. North America: SWOT
51. Europe SWOT
52. Asia Pacific SWOT
53. Latin America SWOT
54. MEA SWOT
55. North America, by country
56. North America
57. North America market estimates and forecast, 2018 - 2030
58. U.S.
59. U.S. market estimates and forecast, 2018 - 2030
60. Canada
61. Canada market estimates and forecast, 2018 - 2030
62. Europe
63. Europe market estimates and forecast, 2018 - 2030
64. U.K.
65. U.K. market estimates and forecast, 2018 - 2030
66. Germany
67. Germany market estimates and forecast, 2018 - 2030
68. France
69. France market estimates and forecast, 2018 - 2030
70. Italy
71. Italy market estimates and forecast, 2018 - 2030
72. Sweden
73. Sweden market estimates and forecast, 2018 - 2030
74. Norway
75. Norway market estimates and forecast, 2018 - 2030
76. Denmark
77. Denmark market estimates and forecast, 2018 - 2030
78. Asia Pacific
79. Asia Pacific market estimates and forecast, 2018 - 2030
80. China
81. China market estimates and forecast, 2018 - 2030
82. Japan
83. Japan market estimates and forecast, 2018 - 2030
84. India
85. India market estimates and forecast, 2018 - 2030
86. South Korea
87. South Korea market estimates and forecast, 2018 - 2030
88. Australia
89. Australia market estimates and forecast, 2018 - 2030
90. Thailand
91. Thailand market estimates and forecast, 2018 - 2030
92. Latin America
93. Latin America market estimates and forecast, 2018 - 2030
94. Brazil
95. Brazil market estimates and forecast, 2018 - 2030
96. Mexico
97. Mexico market estimates and forecast, 2018 - 2030
98. Argentina
99. Argentina market estimates and forecast, 2018 - 2030
100. Middle East and Africa
101. Middle East and Africa. market estimates and forecast, 2018 - 2030
102. South Africa
103. South Africa market estimates and forecast, 2018 - 2030
104. Saudi Arabia
105. Saudi Arabia market estimates and forecast, 2018 - 2030
106. UAE
107. UAE market estimates and forecast, 2018 - 2030
108. Kuwait
109. Kuwait market estimates and forecast, 2018 - 2030
110. Participant categorization- MRI contrast media agents market
111. Market share of key market players- MRI contrast media agents market
Companies Mentioned
- GE Healthcare
- Bayer AG
- Guerbet GmbH
- Bracco Imaging Spa
- Vitalquan, LLC
- Miltenyi Biotec B.V. & Co. Kg
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 110 |
| Published | March 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 1.98 Billion |
| Forecasted Market Value ( USD | $ 3.42 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 6 |
